Modified "Open Intraperitoneal Mesh" Technique of Incisional Ventral Hernia Repair

Not Applicable

Completed

• Conditions: Incisional Ventral Hernia; Recurrent Ventral Hernia

• Registration Number: NCT01953302
• Lead Sponsor: Varazdin General Hospital

Brief Summary

Ventral hernias, primary and recurrent, are major surgical challenge. We aim to investigate efficacy of modified technique of ventral hernias repair: an "open intraperitoneal mesh" technique.

Detailed Description

We analyzed early postoperative complications (EPCs; wound infection, hematoma, and seroma) and late postoperative complications (recurrence) in 124 patients operated for IHs and recurrent IHs (RIHs) using our new technique. Our technique involved repairing hernias by preserving the hernia sac, which was later used to conceal the mesh that replaced the abdominal wall defect, thus dividing the mesh from subcutaneous tissue.

Study Timeline

• Study Start: 2010-05
• Study First Submitted: 2013-09-21
• Study First Submitted QC: 2013-09-25
• Study First Posted: 2013-09-30
• Primary Completion: 2014-05
• Study Completion: 2014-05
• Status Verified: 2017-04
• Results First Submitted: 2023-08-31
• Results First Submitted QC: 2024-04-06
• Last Update Submitted: 2024-04-06
• Results First Posted: 2024-04-12
• Last Update Posted: 2024-04-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 124

Inclusion Criteria

• patients aged 18 years or older
• American Society of Anesthesiologists physical status I, II, III

Exclusion Criteria

• refusal of the patients to give informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Number of Early Postoperative Complications (Wound Infections, Seroma, Hematoma)	four weeks after the surgery	we counted number of patinetns with wound infection, seroma, hematoma that occured in the early postoperative time

Secondary Outcome Measures

Name	Time	Method
Number of Patients With Postoperative Hernia Recurrence	up to 36 months after the surgery

Trial Locations

Locations (1)

Varazdin General Hospital; 🇭🇷 Varazdin, Croatia